BDMD (Baird Medical Investment Holdings) EV-to-EBIT: -3.49 (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BDMD Baird Medical Investment Holdings Ltd BDMD
17 GF Score
Price $1.13
! 7 Warning Signs
View Full Analysis

What is Baird Medical Investment Holdings EV-to-EBIT?

Baird Medical Investment Holdings BDMD +4.10% 17 EV-to-EBIT is -3.49 as of Sep. 09, 2026. GuruFocus rates BDMD with a GF Score™ of 17/100. The stock has 7 warning signs investors should review. Among 475 Medical Devices & Instruments companies, Baird Medical Investment Holdings ranks worse than 210526.11% on this metric.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Baird Medical Investment Holdings's Enterprise Value is $49.92 Mil. Baird Medical Investment Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was $-14.29 Mil. Therefore, Baird Medical Investment Holdings's EV-to-EBIT for today is -3.49.

The historical rank and industry rank for Baird Medical Investment Holdings's EV-to-EBIT or its related term are showing as below:

BDMD' s EV-to-EBIT Range Over the Past 10 Years
Min: -4.1   Med: 4.17   Max: 14.42
Current: -3.49

During the past 5 years, the highest EV-to-EBIT of Baird Medical Investment Holdings was 14.42. The lowest was -4.10. And the median was 4.17.

BDMD's EV-to-EBIT is ranked worse than
100% of 475 companies
in the Medical Devices & Instruments industry
Industry Median: 18.38 vs BDMD: -3.49

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Baird Medical Investment Holdings's Enterprise Value for the quarter that ended in Jun. 2026 was $50.57 Mil. Baird Medical Investment Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was $-14.29 Mil. Baird Medical Investment Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was -28.25%.


Baird Medical Investment Holdings  (NAS:BDMD) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Baird Medical Investment Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2026 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2026 ) =EBIT / Enterprise Value (Q: Jun. 2026 )
=-14.287/50.5653
=-28.25 %

Baird Medical Investment Holdings's Enterprise Value for the quarter that ended in Jun. 2026 was $50.57 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Baird Medical Investment Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was $-14.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baird Medical Investment Holdings EV-to-EBIT Related Terms


Baird Medical Investment Holdings EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Baird Medical Investment Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baird Medical Investment Holdings EV-to-EBIT Chart

Baird Medical Investment Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-EBIT
0.00 0.00 0.00 14.47 -2.37

Baird Medical Investment Holdings Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only 0.00 14.47 0.00 -2.37 0.00

BDMD vs TANAF, NSYS, ARAY: EV-to-EBIT Comparison

For the Medical Devices subindustry, Baird Medical Investment Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baird Medical Investment Holdings EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Baird Medical Investment Holdings's EV-to-EBIT falls into.


BDMD
17GF Score
Baird Medical Investment Holdings Ltd BDMD
EV-to-EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baird Medical Investment Holdings EV-to-EBIT Calculation

Baird Medical Investment Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=49.916/-14.287
=-3.49

Baird Medical Investment Holdings's current Enterprise Value is $49.92 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Baird Medical Investment Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was $-14.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of -3.49 mean?
Baird Medical Investment Holdings (BDMD) has a EV-to-EBIT of -3.49 as of Sep. 09, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Baird Medical Investment Holdings and its competitors. According to the industry distribution chart, Baird Medical Investment Holdings ranks #999999 out of 475 companies in the Medical Devices & Instruments industry.
Is Baird Medical Investment Holdings' EV-to-EBIT too high?
Baird Medical Investment Holdings' current EV-to-EBIT is -3.49. Based on the distribution chart, Baird Medical Investment Holdings ranks #999999 out of 475 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Baird Medical Investment Holdings has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Baird Medical Investment Holdings' EV-to-EBIT compare to TANAF and NSYS?
According to the Medical Devices & Instruments industry distribution chart, Baird Medical Investment Holdings ranks #999999 out of 475 companies for EV-to-EBIT. This places Baird Medical Investment Holdings in the lower half of its industry. The industry median EV-to-EBIT is 18.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.38, based on 475 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Baird Medical Investment Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baird Medical Investment Holdings's current EV-to-EBIT is -3.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baird Medical Investment Holdings stock overvalued right now?
Baird Medical Investment Holdings (BDMD) has a current EV-to-EBIT of -3.49. The current EV-to-EBIT is -3.49. Baird Medical Investment Holdings' overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Baird Medical Investment Holdings (BDMD), the current EV-to-EBIT is -3.49 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Baird Medical Investment Holdings Business Description

Address No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu District, Guangzhou, CHN
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
17GF Score

Get the complete analysis for BDMD

EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.13
Price